10 results on '"Wang, Liqin"'
Search Results
2. Rapid Detection of Predominant SARS-CoV-2 Variants Using Multiplex High-Resolution Melting Analysis.
- Author
-
Sun L, Wang L, Zhang C, Xiao Y, Zhang L, Zhao Z, Ren L, and Peng J
- Subjects
- Humans, Sensitivity and Specificity, Polymerase Chain Reaction, SARS-CoV-2 genetics, COVID-19 diagnosis
- Abstract
Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), poses a considerable threat to global public health. This study developed and evaluated a rapid, low-cost, expandable, and sequencing-free high-resolution melting (HRM) assay for the direct detection of SARS-CoV-2 variants. A panel of 64 common bacterial and viral pathogens that can cause respiratory tract infections was employed to evaluate our method's specificity. Serial dilutions of viral isolates determined the sensitivity of the method. Finally, the assay's clinical performance was assessed using 324 clinical samples with potential SARS-CoV-2 infection. Multiplex HRM analysis accurately identified SARS-CoV-2 (as confirmed with parallel reverse transcription-quantitative PCR [qRT-PCR] tests), differentiating between mutations at each marker site within approximately 2 h. For each target, the limit of detection (LOD) was lower than 10 copies/reaction (the LOD of N, G142D, R158G, Y505H, V213G, G446S, S413R, F486V, and S704L was 7.38, 9.72, 9.96, 9.96, 9.50, 7.80, 9.33, 8.25, and 8.25 copies/reaction, respectively). No cross-reactivity occurred with organisms of the specificity testing panel. In terms of variant detection, our results had a 97.9% (47/48) rate of agreement with standard Sanger sequencing. The multiplex HRM assay therefore offers a rapid and simple procedure for detecting SARS-CoV-2 variants. IMPORTANCE In the face of the current severe situation of increasing SARS-CoV-2 variants, we developed an upgraded multiplex HRM method for the predominant SARS-CoV-2 variants based on our original research. This method not only could identify the variants but also could be utilized in subsequent detection of novel variants since the assay has great performance in terms of flexibility. In summary, the upgraded multiplex HRM assay is a rapid, reliable, and economical detection method, which could better screen prevalent virus strains, monitor the epidemic situation, and help to develop measures for the prevention and control of SARS-CoV-2., Competing Interests: The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
3. Post-Acute COVID-19 Respiratory Symptoms in Patients With Asthma: An Electronic Health Records-Based Study.
- Author
-
Wang L, Foer D, Zhang Y, Karlson EW, Bates DW, and Zhou L
- Subjects
- Humans, SARS-CoV-2, COVID-19 Testing, Retrospective Studies, Electronic Health Records, Cough, Respiratory Sounds, Hospitalization, COVID-19 epidemiology, Bronchial Spasm, Asthma epidemiology
- Abstract
Background: Post-viral respiratory symptoms are common among patients with asthma. Respiratory symptoms after acute COVID-19 are widely reported in the general population, but large-scale studies identifying symptom risk for patients with asthma are lacking., Objective: To identify and compare risk for post-acute COVID-19 respiratory symptoms in patients with and without asthma., Methods: This retrospective, observational cohort study included COVID-19-positive patients between March 4, 2020, and January 20, 2021, with up to 180 days of health care follow-up in a health care system in the Northeastern United States. Respiratory symptoms recorded in clinical notes from days 28 to 180 after COVID-19 diagnosis were extracted using natural language processing. Cohorts were stratified by hospitalization status during the acute COVID-19 period. Univariable and multivariable analyses were used to compare symptoms among patients with and without asthma adjusting for demographic and clinical confounders., Results: Among 31,084 eligible patients with COVID-19, 2863 (9.2%) had hospitalization during the acute COVID-19 period; 4049 (13.0%) had a history of asthma, accounting for 13.8% of hospitalized and 12.9% of nonhospitalized patients. In the post-acute COVID-19 period, patients with asthma had significantly higher risk of shortness of breath, cough, bronchospasm, and wheezing than patients without an asthma history. Incident respiratory symptoms of bronchospasm and wheezing were also higher in patients with asthma. Patients with asthma who had not been hospitalized during acute COVID-19 had additionally higher risk of cough, abnormal breathing, sputum changes, and a wider range of incident respiratory symptoms., Conclusion: Patients with asthma may have an under-recognized burden of respiratory symptoms after COVID-19 warranting increased awareness and monitoring in this population., (Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
4. Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system.
- Author
-
Cucka B, Biglione B, Zhou L, Phillips EJ, Bassir F, Samarakoon U, Rrapi R, Chand S, Wang L, Alvarez-Arango S, Blumenthal KG, and Kroshinsky D
- Subjects
- Delivery of Health Care, Humans, COVID-19, Drug Hypersensitivity Syndrome diagnosis, Drug Hypersensitivity Syndrome etiology, Eosinophilia chemically induced
- Published
- 2022
- Full Text
- View/download PDF
5. COVID-19 severity in asthma patients: a multi-center matched cohort study.
- Author
-
Robinson LB, Wang L, Fu X, Wallace ZS, Long AA, Zhang Y, Camargo CA Jr, and Blumenthal KG
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Boston, COVID-19 mortality, Female, Hospitalization, Humans, Male, Middle Aged, Patient Acuity, Proportional Hazards Models, Respiration, Artificial, SARS-CoV-2, Sex Factors, Asthma epidemiology, COVID-19 epidemiology, COVID-19 physiopathology
- Abstract
Objective: The evidence pertaining to the effects of asthma on Coronavirus disease 2019 outcomes has been unclear. To improve our understanding of the clinically important association of asthma and Coronavirus disease 2019., Methods: A matched cohort study was performed using data from the Mass General Brigham Health Care System (Boston, MA). Adult (age ≥18 years) patients with confirmed Coronavirus disease 2019 and without chronic obstructive pulmonary disease, cystic fibrosis, or interstitial lung disease between March 4, 2020 and July 2, 2020 were analyzed. Up to five non-asthma comparators were matched to each asthma patient based on age (within 5 years), sex, and date of positive test (within 7 days). The primary outcomes were hospitalization, mechanical ventilation, and death, using multivariable Cox-proportional hazards models accounting for competing risk of death, when appropriate. Patients were followed for these outcomes from diagnosis of Coronavirus disease 2019 until July 2, 2020., Results: Among 562 asthma patients, 199 (21%) were hospitalized, 15 (3%) received mechanical ventilation, and 7 (1%) died. Among the 2686 matched comparators, 487 (18%) were hospitalized, 107 (4%) received mechanical ventilation, and 69 (3%) died. The adjusted Hazard Ratios among asthma patients were 0.99 (95% Confidence Internal 0.80, 1.22) for hospitalization, 0.69 (95% Confidence Internal 0.36, 1.29) for mechanical ventilation, and 0.30 (95% Confidence Internal 0.11, 0.80) for death., Conclusions: In this matched cohort study from a large Boston-based healthcare system, asthma was associated with comparable risk of hospitalization and mechanical ventilation but a lower risk of mortality.
- Published
- 2022
- Full Text
- View/download PDF
6. PASCLex: A comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon derived from electronic health record clinical notes.
- Author
-
Wang L, Foer D, MacPhaul E, Lo YC, Bates DW, and Zhou L
- Subjects
- Humans, Natural Language Processing, Prospective Studies, SARS-CoV-2, COVID-19, Electronic Health Records
- Abstract
Objective: To develop a comprehensive post-acute sequelae of COVID-19 (PASC) symptom lexicon (PASCLex) from clinical notes to support PASC symptom identification and research., Methods: We identified 26,117 COVID-19 positive patients from the Mass General Brigham's electronic health records (EHR) and extracted 328,879 clinical notes from their post-acute infection period (day 51-110 from first positive COVID-19 test). PASCLex incorporated Unified Medical Language System® (UMLS) Metathesaurus concepts and synonyms based on selected semantic types. The MTERMS natural language processing (NLP) tool was used to automatically extract symptoms from a development dataset. The lexicon was iteratively revised with manual chart review, keyword search, concept consolidation, and evaluation of NLP output. We assessed the comprehensiveness of PASCLex and the NLP performance using a validation dataset and reported the symptom prevalence across the entire corpus., Results: PASCLex included 355 symptoms consolidated from 1520 UMLS concepts of 16,466 synonyms. NLP achieved an averaged precision of 0.94 and an estimated recall of 0.84. Symptoms with the highest frequency included pain (43.1%), anxiety (25.8%), depression (24.0%), fatigue (23.4%), joint pain (21.0%), shortness of breath (20.8%), headache (20.0%), nausea and/or vomiting (19.9%), myalgia (19.0%), and gastroesophageal reflux (18.6%)., Discussion and Conclusion: PASC symptoms are diverse. A comprehensive lexicon of PASC symptoms can be derived using an ontology-driven, EHR-guided and NLP-assisted approach. By using unstructured data, this approach may improve identification and analysis of patient symptoms in the EHR, and inform prospective study design, preventative care strategies, and therapeutic interventions for patient care., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
7. All-in-one in situ colorimetric RT-LAMP assay for point-of-care testing of SARS-CoV-2.
- Author
-
He Y, Wang L, An X, and Tong Y
- Subjects
- Colorimetry, Humans, Molecular Diagnostic Techniques, Nucleic Acid Amplification Techniques, Point-of-Care Testing, RNA, Viral genetics, Sensitivity and Specificity, COVID-19, SARS-CoV-2
- Abstract
The ongoing outbreaks of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have resulted in unprecedented challenges to global health. To effectively contain the COVID-19 transmission, rapid tests for detecting existing SARS-CoV-2 infections and assessing virus spread are critical. To address the huge need for ever-increasing tests, we developed a facile all-in-one nucleic acid testing assay by combining Si-OH activated glass bead (aGB)-based viral RNA fast extraction and in situ colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) detection in a single tube. aGBs demonstrate a strong ability to capture viral RNA in a guanidinium-based lysis buffer, and the purified aGBs/RNA composite, without RNA elution step, could be directly used to perform RT-LAMP assay. The assay was well characterized by using a novel SARS-CoV-2-like coronavirus GX/P2V, and showed a limit of detection (LOD) of 15 copies per μL in simulated clinical samples within 50 min. We further demonstrated our assay by testing simulated SARS-CoV-2 pseudovirus samples, showing an LOD of 32 copies per μL and high specificity without cross-reactivity with the most closely related GX/P2V or host DNA/RNA. The all-in-one approach developed in this study has the potential as a simple, scalable, and time-saving alternative for point-of-care testing of SARS-CoV-2 in low-income regions, as well as a promising tool for at-home testing.
- Published
- 2021
- Full Text
- View/download PDF
8. The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro.
- Author
-
Fan H, Hong B, Luo Y, Peng Q, Wang L, Jin X, Chen Y, Hu Y, Shi Y, Li T, Zhuang H, Zhou YH, Tong Y, and Xiang K
- Subjects
- Animals, COVID-19 pathology, COVID-19 virology, Humans, Pandemics, Pangolins virology, SARS-CoV-2 pathogenicity, Virus Replication genetics, COVID-19 genetics, SARS-CoV-2 genetics, Spike Glycoprotein, Coronavirus genetics, Whey Proteins genetics
- Published
- 2020
- Full Text
- View/download PDF
9. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus
- Author
-
Yigang Tong, Chen Yangzhen, Chenyang Lu, Wang Liqin, Huahao Fan, Wenlin An, Xiaoping An, Lihua Song, Liu Wenli, and Shasha Li
- Subjects
AcademicSubjects/SCI01060 ,viruses ,Biology ,medicine.disease_cause ,Antiviral Agents ,Benzylisoquinolines ,Virus ,Transcriptome ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,cellular stress ,cepharanthine ,Chlorocebus aethiops ,medicine ,Cepharanthine ,Animals ,Homeostasis ,Humans ,Heat shock ,HSF1 ,Vero Cells ,Molecular Biology ,030304 developmental biology ,Coronavirus ,0303 health sciences ,Case Study ,SARS-CoV-2 ,Endoplasmic reticulum ,COVID-19 ,GX_P2V ,Virology ,chemistry ,030220 oncology & carcinogenesis ,Unfolded protein response ,Information Systems - Abstract
Antiviral therapies targeting the pandemic coronavirus disease 2019 (COVID-19) are urgently required. We studied an already-approved botanical drug cepharanthine (CEP) in a cell culture model of GX_P2V, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related virus. RNA-sequencing results showed the virus perturbed the expression of multiple genes including those associated with cellular stress responses such as endoplasmic reticulum (ER) stress and heat shock factor 1 (HSF1)-mediated heat shock response, of which heat shock response-related genes and pathways were at the core. CEP was potent to reverse most dysregulated genes and pathways in infected cells including ER stress/unfolded protein response and HSF1-mediated heat shock response. Additionally, single-cell transcriptomes also confirmed that genes of cellular stress responses and autophagy pathways were enriched in several peripheral blood mononuclear cells populations from COVID-19 patients. In summary, this study uncovered the transcriptome of a SARS-CoV-2-related coronavirus infection model and anti-viral activities of CEP, providing evidence for CEP as a promising therapeutic option for SARS-CoV-2 infection.
- Published
- 2021
10. Transcriptome analysis of cepharanthine against a SARS-CoV-2-related coronavirus.
- Author
-
Li, Shasha, Liu, Wenli, Chen, Yangzhen, Wang, Liqin, An, Wenlin, An, Xiaoping, Song, Lihua, Tong, Yigang, Fan, Huahao, and Lu, Chenyang
- Subjects
COVID-19 ,MONONUCLEAR leukocytes ,MEDICAL botany ,COVID-19 pandemic ,UNFOLDED protein response ,PANDEMICS ,ENDOPLASMIC reticulum - Abstract
Antiviral therapies targeting the pandemic coronavirus disease 2019 (COVID-19) are urgently required. We studied an already-approved botanical drug cepharanthine (CEP) in a cell culture model of GX_P2V, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related virus. RNA-sequencing results showed the virus perturbed the expression of multiple genes including those associated with cellular stress responses such as endoplasmic reticulum (ER) stress and heat shock factor 1 (HSF1)-mediated heat shock response, of which heat shock response-related genes and pathways were at the core. CEP was potent to reverse most dysregulated genes and pathways in infected cells including ER stress/unfolded protein response and HSF1-mediated heat shock response. Additionally, single-cell transcriptomes also confirmed that genes of cellular stress responses and autophagy pathways were enriched in several peripheral blood mononuclear cells populations from COVID-19 patients. In summary, this study uncovered the transcriptome of a SARS-CoV-2-related coronavirus infection model and anti-viral activities of CEP, providing evidence for CEP as a promising therapeutic option for SARS-CoV-2 infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.